Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The price of Fulcrum Therapeutics Inc (NASDAQ: FULC) closed at $5.35 in the last session, down -6.63% from day before closing price of $5.73. In other words, the price has decreased by -$6.63 from its previous closing price. On the day, 0.89 million shares were traded.
Ratios:
We take a closer look at FULC’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.27 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 38.20. For the most recent quarter (mrq), Quick Ratio is recorded 28.71 and its Current Ratio is at 28.71. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, H.C. Wainwright on September 13, 2024, Downgraded its rating to Neutral and sets its target price to $4 from $17 previously.
RBC Capital Mkts Downgraded its Outperform to Sector Perform on September 12, 2024, whereas the target price for the stock was revised from $15 to $4.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 3.61 while its Price-to-Book (P/B) ratio in mrq is 1.26.
Stock Price History:
Over the past 52 weeks, FULC has reached a high of $10.13, while it has fallen to a 52-week low of $2.32. The 50-Day Moving Average of the stock is 62.04%, while the 200-Day Moving Average is calculated to be 15.82%.
Shares Statistics:
A total of 53.98M shares are outstanding, with a floating share count of 47.85M. Insiders hold about 11.36% of the company’s shares, while institutions hold 88.89% stake in the company.
